top of page

Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study

About the study

NCT Trial Number

NCT01943994

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Johns Hopkins University|Beckley Foundation|Heffter Research Institute

noun_date_3237048.png

Trial Start Date

Sep-08

noun_capsule_138144.png

About the participants

Age seeking

21 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Nicotine Dependence

noun_square_138133.png

Accepts healthy volunteers?

Yes

A study to examine the efficacy of combined treatment of psilocybin with a structured smoking cessation treatment program in nicotine dependent individuals.

Eyes Graffiti

Locations

United States, Maryland
Behavioral Pharmacology Research Unit
Baltimore, Maryland, United States, 21224

Contact: Albert P Garcia-Romeu, PhD
410-550-1972
AGarci33@jhmi.edu

Neuroimaging Research Branch, NIDA-IRP
Baltimore, Maryland, United States, 21224
Contact: John Fedota, PhD
443-740-2782
john.fedota@nih.gov

Contact: Carolina Smith, MS
4437402624
smithcaro@nida.nih.gov

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page